| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |